HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM

Clinical trials for HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM explained in plain language.

Never miss a new study

Get alerted when new HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM trials appear

Sign up with your email to follow new studies for HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists trace new Drug's path in dialysis patients

Knowledge-focused Recruiting now

This early-stage study aims to understand how the body processes and eliminates a new experimental drug called MT1013. It will involve 6 adults with a specific bone and mineral disorder related to kidney failure who are on regular dialysis. The main goal is to track where the dru…

Matched conditions: HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM

Phase: PHASE1 • Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused

Last updated Mar 23, 2026 15:14 UTC

HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM

Get alerted when new HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM trials appear

Scientists trace new Drug's path in dialysis patients